Head of Unit – Health Department
Supervises the overall implementation and management of the project team, she is particularly in charge of organisational, institutional and political relations within Expertise France (with Senior Management, technical and support units) and externally, with various stakeholders (members of MEDISAFE consortium, EC HQ, CBRN CoE Regional Secretariat, French Ministry of Foreign Affairs, French diplomatic network, WHO, UNODC etc.)
Project Manager – Health Department
Ensures the operational management and monitoring of the project, coordination of the consortium and contractual and institutional relations with the European Commission and partner countries. He is the focal point for any general questions about the project.
Project Officer – Health Department
Ensures the technical and logistical implementation of the project. In charge of the contractualisation of international and national experts as well as the management of external partners.Follow
Project Assistant – Health Department
Ensures operational and logistical follow up as a support to the project manager and the project officer. She is in charge of the financial and administrative monitoring of the project and the management of communication tools.Follow
Key expert 2 – Legal expert
Amélie Robine has a Master’s degree in law and development financing (IDPD, Nice) and a PhD in international economic law (University of Paris I – Sorbonne Paris). She began her career as a Legal Researcher dedicating several years in studying and analyzing pharmaceutical technology transfer contracts, reconciliation of pharmaceutical patent law and health law based on an international multidisciplinary approach (Brazil, India, Thailand). Then, she spent two years in a law firm in Paris specialized in health law and working on medical law, pharmaceutical law, social security law and pharmaceuticals ethics. Then she joined a law firm in international affairs specialized in trade, competition and business criminal law before starting her own firm in January 2014.
Key expert 3 – Pharmaceutical expert
Alexandre DE LA VOLPILIERE